These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 23379513)

  • 1. Adeno-associated viral-mediated LARGE gene therapy rescues the muscular dystrophic phenotype in mouse models of dystroglycanopathy.
    Yu M; He Y; Wang K; Zhang P; Zhang S; Hu H
    Hum Gene Ther; 2013 Mar; 24(3):317-30. PubMed ID: 23379513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adeno-associated virus-mediated overexpression of LARGE rescues α-dystroglycan function in dystrophic mice with mutations in the fukutin-related protein.
    Vannoy CH; Xu L; Keramaris E; Lu P; Xiao X; Lu QL
    Hum Gene Ther Methods; 2014 Jun; 25(3):187-96. PubMed ID: 24635668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
    Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
    Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fukutin is prerequisite to ameliorate muscular dystrophic phenotype by myofiber-selective LARGE expression.
    Ohtsuka Y; Kanagawa M; Yu CC; Ito C; Chiyo T; Kobayashi K; Okada T; Takeda S; Toda T
    Sci Rep; 2015 Feb; 5():8316. PubMed ID: 25661440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
    Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F
    Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies.
    Grewal PK; McLaughlan JM; Moore CJ; Browning CA; Hewitt JE
    Glycobiology; 2005 Oct; 15(10):912-23. PubMed ID: 15958417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LARGE can functionally bypass alpha-dystroglycan glycosylation defects in distinct congenital muscular dystrophies.
    Barresi R; Michele DE; Kanagawa M; Harper HA; Dovico SA; Satz JS; Moore SA; Zhang W; Schachter H; Dumanski JP; Cohn RD; Nishino I; Campbell KP
    Nat Med; 2004 Jul; 10(7):696-703. PubMed ID: 15184894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study.
    Mercuri E; Messina S; Bruno C; Mora M; Pegoraro E; Comi GP; D'Amico A; Aiello C; Biancheri R; Berardinelli A; Boffi P; Cassandrini D; Laverda A; Moggio M; Morandi L; Moroni I; Pane M; Pezzani R; Pichiecchio A; Pini A; Minetti C; Mongini T; Mottarelli E; Ricci E; Ruggieri A; Saredi S; Scuderi C; Tessa A; Toscano A; Tortorella G; Trevisan CP; Uggetti C; Vasco G; Santorelli FM; Bertini E
    Neurology; 2009 May; 72(21):1802-9. PubMed ID: 19299310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired viability of muscle precursor cells in muscular dystrophy with glycosylation defects and amelioration of its severe phenotype by limited gene expression.
    Kanagawa M; Yu CC; Ito C; Fukada S; Hozoji-Inada M; Chiyo T; Kuga A; Matsuo M; Sato K; Yamaguchi M; Ito T; Ohtsuka Y; Katanosaka Y; Miyagoe-Suzuki Y; Naruse K; Kobayashi K; Okada T; Takeda S; Toda T
    Hum Mol Genet; 2013 Aug; 22(15):3003-15. PubMed ID: 23562821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adeno-associated virus 9 mediated FKRP gene therapy restores functional glycosylation of α-dystroglycan and improves muscle functions.
    Xu L; Lu PJ; Wang CH; Keramaris E; Qiao C; Xiao B; Blake DJ; Xiao X; Lu QL
    Mol Ther; 2013 Oct; 21(10):1832-40. PubMed ID: 23817215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Alpha-dystroglycanopathy (FCMD, MEB, etc): abnormal glycosylation and muscular dystrophy].
    Toda T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):932-4. PubMed ID: 16447766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pikachurin interaction with dystroglycan is diminished by defective O-mannosyl glycosylation in congenital muscular dystrophy models and rescued by LARGE overexpression.
    Hu H; Li J; Zhang Z; Yu M
    Neurosci Lett; 2011 Feb; 489(1):10-5. PubMed ID: 21129441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathomechanism and therapeutic strategy of Fukuyama congenital muscular dystrophy and related disorders].
    Toda T
    Rinsho Shinkeigaku; 2009 Nov; 49(11):859-62. PubMed ID: 20030231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous glucuronyltransferase activity of LARGE or LARGE2 required for functional modification of α-dystroglycan in cells and tissues.
    Inamori K; Willer T; Hara Y; Venzke D; Anderson ME; Clarke NF; Guicheney P; Bönnemann CG; Moore SA; Campbell KP
    J Biol Chem; 2014 Oct; 289(41):28138-48. PubMed ID: 25138275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. POMGnT1, POMT1, and POMT2 mutations in congenital muscular dystrophies.
    Endo T; Manya H; Seta N; Guicheney P
    Methods Enzymol; 2010; 479():343-52. PubMed ID: 20816175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycomic analyses of mouse models of congenital muscular dystrophy.
    Stalnaker SH; Aoki K; Lim JM; Porterfield M; Liu M; Satz JS; Buskirk S; Xiong Y; Zhang P; Campbell KP; Hu H; Live D; Tiemeyer M; Wells L
    J Biol Chem; 2011 Jun; 286(24):21180-90. PubMed ID: 21460210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous intramuscular transplantation of engineered satellite cells induces exosome-mediated systemic expression of Fukutin-related protein and rescues disease phenotype in a murine model of limb-girdle muscular dystrophy type 2I.
    Frattini P; Villa C; De Santis F; Meregalli M; Belicchi M; Erratico S; Bella P; Raimondi MT; Lu Q; Torrente Y
    Hum Mol Genet; 2017 Oct; 26(19):3682-3698. PubMed ID: 28666318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital muscular dystrophy with muscle inflammation alpha dystroglycan glycosylation defect and no mutation in FKRP gene.
    Lamperti C; Cagliani R; Ciscato P; Moroni I; Viri M; Romeo A; Fagiolari G; Prelle A; Comi GP; Bresolin N; Moggio M
    J Neurol Sci; 2006 Apr; 243(1-2):47-51. PubMed ID: 16386759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LARGE expression in different types of muscular dystrophies other than dystroglycanopathy.
    Balci-Hayta B; Talim B; Kale G; Dincer P
    BMC Neurol; 2018 Dec; 18(1):207. PubMed ID: 30553274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
    Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
    Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.